Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biorestorative Therapies Inc
(NQ:
BRTX
)
1.640
+0.010 (+0.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biorestorative Therapies Inc
< Previous
1
2
3
4
5
Next >
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 01, 2024
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 18, 2023
Via
Benzinga
COMPASS Pathways Is Accelerating Patient Access To Evidence-Based Innovation In Mental Health Care
October 05, 2023
The Current Landscape Of Mental Health Is Failing Patients
Via
Benzinga
Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved"
September 14, 2023
BioRestorative Therapies Inc. (NASDAQ: BRTX) (“BioRestorative”) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions...
Via
Benzinga
EXCLUSIVE: Stem Cell Focused BioRestorative Ventures Into $63B Aesthetics Market Via Supply Agreement With Evolutionary Biologics
September 12, 2023
BioRestorative Therapies Inc (NASDAQ: BRTX) has entered into a supply agreement with Evolutionary Biologics, a supplier of biologic-based cosmetics.
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 06, 2023
Via
Benzinga
BioRestorative Therapies And 3 Other Stocks Under $3 Insiders Are Buying
September 01, 2023
The Dow Jones closed lower by over 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
August 29, 2023
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the population will experience back pain at some point.
Via
Benzinga
BioRestorative Therapies Gains Additional Investor Confidence As Insider Dale Broadrick, CEO Lance Alstodt Purchase Thousands of Shares
August 01, 2023
Valuations, competitive landscape and market opportunity are fundamental characteristics in evaluating investment decisions. Insider buying – the “smart money” – can also be an indicator to evaluate...
Via
Benzinga
Over $4M Bet On Yellow Corp? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
July 31, 2023
The Dow Jones closed higher on Friday, also recording gains for the week. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform – Insights From The Discussion
July 27, 2023
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually.
Via
Benzinga
$5.7M Bet On This Tech Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
July 26, 2023
The Dow Jones closed higher on Tuesday, recording gains for the 12th straight session. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects....
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 25, 2023
On Tuesday, 56 companies set new 52-week lows.
Via
Benzinga
Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 21, 2023
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC.
Via
Benzinga
BioRestorative Therapies (NASDAQ: BRTX) Receives Landmark License From New York State
July 20, 2023
BioRestorative Therapies Inc. (NASDAQ: BRTX) (“BioRestorative”), a clinical-stage company specializing in stem cell-based therapies, has announced that it has been granted a license by the New York...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 11, 2023
Via
Benzinga
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 11, 2023
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.
Via
Benzinga
Why BioRestorative Therapies (BRTX) Stock Is Getting Hammered
July 11, 2023
BioRestorative Therapies Inc (NASDAQ: BRTX) shares are trading lower by 17.13% to $2.95 Tuesday morning after the company announced a $2.1 million registered direct offe
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
July 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 10, 2023
Via
Benzinga
BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities
July 06, 2023
BioRestorative Therapies Inc. (NASDAQ: BRTX) has received a unanimous recommendation to proceed in its Phase 2 clinical trial for chronic lumb
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 27, 2023
Via
Benzinga
EXCLUSIVE: Data Monitoring Committee Allows BioRestorative's Chronic Lumbar Disc Disease Study To Continue Unchanged
June 27, 2023
BioRestorative Therapies Inc (NASDAQ: BRTX) has announced that the independent Data Safety Monitoring Board (DSMB), overseeing the company's ongoing Phase 2 trial to treat chronic lumbar disc disease,...
Via
Benzinga
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 26, 2023
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...
Via
Benzinga
Metabolic Syndrome: The Silent Epidemic On The Rise And How BioRestorative Therapies Inc. Is Helping Fight It
June 14, 2023
Once a lesser-known health condition, now a problem crippling millions of people around the world: metabolic syndrome is unfortunately on the rise.
Via
Benzinga
EXCLUSIVE: BioRestorative Completes Dosing In Safety Cohort Of Chronic Lower Back Pain Trial
June 12, 2023
BioRestorative Therapies Inc (NASDAQ: BRTX) announced that the final subject in its BRTX-100 Phase 2 trial safety cohort has been dosed.
Via
Benzinga
EXCLUSIVE: BioRestorative Therapies Wins License from New York State Department of Health To Act As Tissue Bank for Mesenchymal Stem Cell Processing
May 31, 2023
BioRestorative Therapies, Inc (NASDAQ: BRTX), bagged a license from the New York State Department of Health to act as a tissue bank for processing
Via
Benzinga
A Cure For Back Pain? Phase II Clinical Trials Begin For Promising Drug Candidate
May 25, 2023
Dr. Jason Lipetz, MD, Physiatrist & Head of Spine Medicine at Northwell Health, was recently interviewed by Benzinga. Dr. Lipetz is currently assisting BioRestorative Therapies, Inc (NASDAQ: BRTX) in...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.